Standout Papers

High-performance medicine: the ... 2002 2026 2010 2018 3.4k
  1. High-performance medicine: the convergence of human and artificial intelligence (2018)
    Eric J. Topol Nature Medicine
  2. Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention (2002)
    Steven R. Steinhubl, Peter B. Berger et al. JAMA
  3. Long COVID: major findings, mechanisms and recommendations (2023)
    Hannah Davis, Lisa McCorkell et al. Nature Reviews Microbiology
  4. Prevalence of Asymptomatic SARS-CoV-2 Infection (2020)
    Eric J. Topol et al. Annals of Internal Medicine
  5. AI in health and medicine (2022)
    Pranav Rajpurkar, Emma Chen et al. Nature Medicine
  6. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. (1990)
    Sam Ellis, Michel Vandormael et al. Circulation
  7. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy (2003)
    Arman T. Askari, Samuel Unzek et al. The Lancet
  8. A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis (2019)
    Xiaoxuan Liu, Livia Faes et al. The Lancet Digital Health
  9. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade (1998)
    Eric J. Topol The Lancet
  10. Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction (1995)
    Kerry L. Lee, Lynn H. Woodlief et al. Circulation
  11. Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia (1996)
    E. Magnus Ohman, Paul W. Armstrong et al. New England Journal of Medicine
  12. Aortocoronary Saphenous Vein Graft Disease (1998)
    Joseph G. Motwani, Eric J. Topol Circulation
  13. Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention (2003)
    A. Michael Lincoff, John A. Bittl et al. JAMA
  14. The personal and clinical utility of polygenic risk scores (2018)
    Ali Torkamani, Nathan E. Wineinger et al. Nature Reviews Genetics
  15. Prognostic Value of Myeloperoxidase in Patients with Chest Pain (2003)
    Marie‐Luise Brennan, Marc S. Penn et al. New England Journal of Medicine
  16. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease (2003)
    Patricia A. Gum, Kandice Kottke‐Marchant et al. Journal of the American College of Cardiology
  17. State of Telehealth (2016)
    E. Ray Dorsey, Eric J. Topol New England Journal of Medicine
  18. Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure (2004)
    Steven E. Nissen, E. Murat Tuzcu et al. JAMA
  19. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials (2003)
    Deepak P. Vivekananthan, Marc S. Penn et al. The Lancet
  20. Our Preoccupation With Coronary Luminology (1995)
    Eric J. Topol, Steven E. Nissen Circulation
  21. A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction (1987)
    Eric J. Topol, Robert M. Califf et al. New England Journal of Medicine
  22. Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation (2000)
    Eric Boersma, Karen S. Pieper et al. Circulation
  23. Textbook of Cardiovascular Medicine (1997)
    Eric J. Topol Medical Entomology and Zoology
  24. Human genetic variation and its contribution to complex traits (2009)
    Kelly A. Frazer, Sarah S. Murray et al. Nature Reviews Genetics
  25. Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries (1996)
    Willem J. van der Giessen, A. Michael Lincoff et al. Circulation
  26. Sex, Clinical Presentation, and Outcome in Patients with Acute Coronary Syndromes (1999)
    Judith S. Hochman, J.E. Tamis et al. New England Journal of Medicine
  27. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials (2002)
    Eric Boersma, Robert A. Harrington et al. The Lancet
  28. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months (1994)
    Eric J. Topol, R.M. Califf et al. The Lancet
  29. Profile and prevalence of aspirin resistance in patients with cardiovascular disease (2001)
    Patricia A. Gum, Kandice Kottke‐Marchant et al. The American Journal of Cardiology
  30. Foundation models for generalist medical artificial intelligence (2023)
    Michael Moor, Oishi Banerjee et al. Nature
  31. Deep learning-enabled medical computer vision (2021)
    Andre Esteva, Katherine Chou et al. npj Digital Medicine
  32. Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease (2000)
    Eric J. Topol, Jay S. Yadav Circulation
  33. Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies (2020)
    Myura Nagendran, Yang Chen et al. BMJ
  34. Variability in platelet responsiveness to clopidogrel among 544 individuals (2005)
    Victor L. Serebruany, Steven R. Steinhubl et al. Journal of the American College of Cardiology
  35. Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine (1995)
    Jeffrey Lefkovits, Edward F. Plow et al. New England Journal of Medicine
  36. Protein carbamylation links inflammation, smoking, uremia and atherogenesis (2007)
    Zeneng Wang, Stephen J. Nicholls et al. Nature Medicine
  37. Assessing the impact of population stratification on genetic association studies (2004)
    Matthew L. Freedman, David Reich et al. Nature Genetics
  38. Applications of digital technology in COVID-19 pandemic planning and response (2020)
    Sera Whitelaw, Mamas A. Mamas et al. The Lancet Digital Health
  39. Cause of death in clinical research (1999)
    Michael S. Lauer, Eugene H. Blackstone et al. Journal of the American College of Cardiology
  40. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms (1992)
    Robert S. Schwartz, David R. Holmes et al. Journal of the American College of Cardiology
  41. The emerging field of mobile health (2015)
    Steven R. Steinhubl, Evan D. Muse et al. Science Translational Medicine
  42. Multimodal biomedical AI (2022)
    Julián Acosta, Guido J. Falcone et al. Nature Medicine
  43. The imperative for regulatory oversight of large language models (or generative AI) in healthcare (2023)
    Bertalan Meskó, Eric J. Topol npj Digital Medicine
  44. Adapting to Artificial Intelligence (2016)
    Saurabh Kumar Jha, Eric J. Topol JAMA
  45. The Proportion of SARS-CoV-2 Infections That Are Asymptomatic (2021)
    Eric J. Topol et al. Annals of Internal Medicine
  46. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation (2018)
    Steven R. Steinhubl, Jill Waalen et al. JAMA
  47. Self-supervised learning in medicine and healthcare (2022)
    Rayan Krishnan, Pranav Rajpurkar et al. Nature Biomedical Engineering
  48. Telemedicine 2020 and the next decade (2020)
    E. Ray Dorsey, Eric J. Topol The Lancet
  49. Long COVID science, research and policy (2024)
    Ziyad Al‐Aly, Hannah Davis et al. Nature Medicine
  50. Author Correction: Long COVID: major findings, mechanisms and recommendations (2023)
    Hannah Davis, Lisa McCorkell et al. Nature Reviews Microbiology
  51. Three-year outcomes of post-acute sequelae of COVID-19 (2024)
    Miao Cai, Yan Xie et al. Nature Medicine
  52. Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review (2024)
    Julián Acosta, Eric J. Topol et al. The Lancet Digital Health
  53. Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice (2024)
    Rohan Khera, Evangelos K. Oikonomou et al. Journal of the American College of Cardiology
  54. Solving the puzzle of Long Covid (2024)
    Ziyad Al‐Aly, Eric J. Topol Science
  55. Artificial intelligence in surgery (2024)
    Chris Varghese, Ewen M. Harrison et al. Nature Medicine
  56. The rise of agentic AI teammates in medicine (2025)
    James Zou, Eric J. Topol The Lancet

Immediate Impact

1 by Nobel laureates 27 from Science/Nature 136 standout
Sub-graph 1 of 23

Citing Papers

Mass-spectrometry-based proteomics: from single cells to clinical applications
2025 StandoutNature
A vision–language foundation model for precision oncology
2025 StandoutNature
1 intermediate paper

Works of Eric J. Topol being referenced

Foundation models for generalist medical artificial intelligence
2023 StandoutNature
Multimodal biomedical AI
2022 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Eric J. Topol 61293 40725 22586 1.3k 108.3k
Valentı́n Fuster 52301 33107 22414 1.3k 98.0k
Salim Yusuf 104588 28566 10678 1.3k 156.2k
Deepak L. Bhatt 55509 38853 7586 2.0k 103.4k
Ralph B. D’Agostino 57880 28135 12194 1.4k 169.3k
Daniel Levy 88384 24628 13500 807 138.9k
Stuart Pocock 34883 31770 6318 569 137.2k
William B. Kannel 69673 22477 10500 475 125.2k
David R. Holmes 62505 41217 24862 1.4k 87.2k
Emelia J. Benjamin 68687 11568 9327 766 98.8k
Peter Libby 34775 38575 9762 757 144.2k

All Works

Loading papers...

Rankless by CCL
2026